ModernMedicine Resource Center More Topics

Ocular Allergy Resource Center

Allergy or dry eye: Which is it?Ocular surface disease may be multifactorial, presenting a challenge to the physician in making a correct diagnosis and management plan.
Rethinking once-daily dosing on allergy medicationsIdeally, an ocular allergy medication should provide clinically significant improvements of the annoying or even incapacitating ocular itch with minimal dosing. While this is a desirable goal, it leads to challenges of the amount of dosing to achieve this objective and patient compliance with such dosing.
How to improve diagnosis and treatment of allergy
How to improve diagnosis and treatment of allergyIf you think more allergy patients are landing in your chair every year, you’re absolutely correct. The prevalence of allergy is rising worldwide to near epidemic proportions and carries a significant burden for both the individual patient as well as healthcare systems globally.
What Thomas Edison and goldenrod teach us about allergyRight about now, you are probably wondering, “Is there a real connection between the plant and the late inventor?”
Allergy-free prescriptions: A need for information gives birth to a new platform
Allergy-free prescriptions: A need for information gives birth to a new platformThe next time your patient asks about inactive ingredients, you can find an answer quickly at www.allergyfreerx.com.
A new player in point-of-care allergy testing
A new player in point-of-care allergy testingWhat would be the response if I told you that prescribing an allergy medication outright was a bandage or knee-jerk approach? Now, before everyone comes after me with pitchforks, hear me out.
The increasing role of climate, hygiene, and aerobiology in allergyWith Earth’s climate change, both higher temperature and carbon dioxide levels have been inducing vigorous amounts of allergen production from multiple plant and tree species blooming faster than expected for at least the past 160 years.
Dual-acting, anti-allergy agent delivers efficacy, safety, convenienceOlopatadine 0.2% is a well-tolerated, safe, and effective antihistamine/mast cell stabilizer for treating mild to severe allergic conjunctivitis in children and adults.
Anti-allergic agent alcaftadine stronger in relief of ocular itchingIn head-to-head clinical assessments, alcaftadine was found to be statistically and clinically superior to olopatadine for relief of allergic conjunctivitis.
Novel dexamethasone punctum plug for ocular allergy shows promiseA novel dexamethasone-eluting punctum plug was safe and showed some evidence of efficacy for relieving signs and symptoms of allergic conjunctivitis in a phase II study.